Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,24 USD | -6,81% | -5,36% | -18,93% |
11/03 | Sectorupdate: Aandelen gezondheidszorg eind van de middag zachter | MT |
11/03 | Sectorupdate: Gezondheidszorg | MT |
Omzet 2021 | 172 mln. 160 mln. | Omzet 2022 | 317 mln. 295 mln. | Marktkapitalisatie | 380 mln. 355 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -8 mln. -7,46 mln. | Nettowinst (verlies) 2022 | 35 mln. 32,63 mln. | EV/omzet 2021 | 3,44 x |
Nettoliquiditeiten 2021 | 67,84 mln. 63,24 mln. | Nettoschuld 2022 | 10,19 mln. 9,5 mln. | EV/omzet 2022 | 1,23 x |
K/w-verhouding 2021 |
-77
x | K/w-verhouding 2022 |
10,7
x | Werknemers | 134 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 65,14% |
Recentste transcriptie over Eagle Pharmaceuticals, Inc.
1 dag | -6,81% | ||
1 week | -5,36% | ||
Lopende maand | -19,08% | ||
1 maand | -16,54% | ||
3 maanden | -20,00% | ||
6 maanden | -68,73% | ||
Lopend jaar | -18,93% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Graves
CEO | Chief Executive Officer | 61 | 01-11-13 |
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 01-03-07 |
Ryan Debski
CMP | Compliance Officer | - | 01-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 01-03-07 |
Jennifer Simpson
BRD | Director/Board Member | 55 | 28-08-19 |
Richard Edlin
BRD | Director/Board Member | 63 | 17-03-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.54% | 29 M€ | -4,59% | ||
0.25% | 27 M€ | -5,44% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 4,24 | -6,81% | 130 160 |
24-04-24 | 4,55 | -4,61% | 95 218 |
23-04-24 | 4,77 | +4,84% | 88 216 |
22-04-24 | 4,55 | -1,30% | 283 208 |
19-04-24 | 4,61 | +2,90% | 59 516 |
uitgestelde koers Nasdaq, 25 april 2024 om 22:00 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-18,93% | 59,09 mln. | |
+4,16% | 70,78 mld. | |
+10,44% | 9,15 mld. | |
-17,03% | 4,84 mld. | |
+37,51% | 4,22 mld. | |
+3,92% | 3,92 mld. | |
+18,14% | 2,55 mld. | |
-24,13% | 2,26 mld. | |
-29,70% | 2,24 mld. | |
+9,09% | 1,92 mld. |